Filter programs:

47 Programs

  • Interview and Lecture

    Exploring the Potential Role of PROTAC Estrogen Receptor Degraders in the Management of HR-Positive Metastatic Breast Cancer

    Explore program
    • October 2025 1.25 ABIM MOC, ABS MOC 58min
      • E
      Dr Hamilton
    • October 2025 0.75 ABIM MOC, ABS MOC 29min
      • E
      Dr Hamilton
  • Oncology Today with Dr Neil Love

    The Role of Oral Selective Estrogen Receptor Degraders in the Management of ER-Positive Metastatic Breast Cancer

    Explore program
  • Oncology Today with Dr Neil Love

    Optimizing the Integration of ADCs into the Treatment of HR-Positive and Triple-Negative Metastatic Breast Cancer

    Explore program
    • October 2025 1 ABIM MOC, ABS MOC, CME 43min
      • L
      Dr Huppert
    • October 2025 0.75 ABIM MOC, ABS MOC, CME 31min
      • L
      Dr Huppert
  • Webinar Proceedings

    Current and Future Integration of Antibody-Drug Conjugates into the Management of Metastatic Breast Cancer

    Explore program